Ted was most recently a principal and founder of Super Vitamin D, LLC. Prior to his work with SVD, LLC, he was CEO and Chairman of Dermatrends, a transdermal drug delivery tech company, where he raised over $20 million in funding. He was an advisor to Ethicon Endo-Surgery, a division of Johnson & Johnson, in new product development & acquisitions. Ted is a principal at Ted K. Schwarzrock, LLC, a strategic consulting firm focusing on the discovery and development of innovation in the medical device, biotech, drug delivery and pharmaceutical industries. Ted has helped start and grow 5 early stage companies during his career.

• $55MM in revenue in the first year of sales following FDA listing at SpineTech, Inc.

• Grew Ergodyne Corporation’s sales from $10MM to over $42MM in less than 3 years.

• Doubled BioMedical Dynamics sales within 12 months resulting in acquisition

• Grew Aequitron Medical from startup to over $25MM in sales resulting in $60MM exit